FdaApplication

NDA 021392

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBAUSCH HEALTH US LLC
application_typeNDA
approval_date2003-02-06

Products (6)

ProductActive ingredientStrengthDosage form
CARDIZEM LADILTIAZEM HYDROCHLORIDE360MGTABLET, EXTENDED RELEASE;ORAL
CARDIZEM LADILTIAZEM HYDROCHLORIDE180MGTABLET, EXTENDED RELEASE;ORAL
CARDIZEM LADILTIAZEM HYDROCHLORIDE300MGTABLET, EXTENDED RELEASE;ORAL
CARDIZEM LADILTIAZEM HYDROCHLORIDE420MGTABLET, EXTENDED RELEASE;ORAL
CARDIZEM LADILTIAZEM HYDROCHLORIDE120MGTABLET, EXTENDED RELEASE;ORAL
CARDIZEM LADILTIAZEM HYDROCHLORIDE240MGTABLET, EXTENDED RELEASE;ORAL

6 products